Elicio Therapeutics Statistics
Total Valuation
ELTX has a market cap or net worth of $78.44 million. The enterprise value is $62.57 million.
Important Dates
The last earnings date was Monday, March 31, 2025, before market open.
| Earnings Date | Mar 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ELTX has 15.85 million shares outstanding. The number of shares has increased by 141.35% in one year.
| Current Share Class | 15.85M |
| Shares Outstanding | 15.85M |
| Shares Change (YoY) | +141.35% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 35.90% |
| Owned by Institutions (%) | 13.20% |
| Float | 9.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -7.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.80
| Current Ratio | 1.80 |
| Quick Ratio | 1.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -170,157.38% and return on invested capital (ROIC) is -805.85%.
| Return on Equity (ROE) | -170,157.38% |
| Return on Assets (ROA) | -101.64% |
| Return on Invested Capital (ROIC) | -805.85% |
| Return on Capital Employed (ROCE) | -270.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.62M |
| Employee Count | 32 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.97% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -31.97% |
| 50-Day Moving Average | 8.09 |
| 200-Day Moving Average | 5.73 |
| Relative Strength Index (RSI) | 24.47 |
| Average Volume (20 Days) | 39,409 |
Short Selling Information
The latest short interest is 170,043, so 1.07% of the outstanding shares have been sold short.
| Short Interest | 170,043 |
| Short Previous Month | 161,508 |
| Short % of Shares Out | 1.07% |
| Short % of Float | 1.71% |
| Short Ratio (days to cover) | 4.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -44.99M |
| Pretax Income | -38.99M |
| Net Income | -51.90M |
| EBITDA | -44.67M |
| EBIT | -44.99M |
| Earnings Per Share (EPS) | -$4.25 |
Full Income StatementBalance Sheet
The company has $17.62 million in cash and n/a in debt, giving a net cash position of $17.62 million or $1.11 per share.
| Cash & Cash Equivalents | 17.62M |
| Total Debt | n/a |
| Net Cash | 17.62M |
| Net Cash Per Share | $1.11 |
| Equity (Book Value) | -11.31M |
| Book Value Per Share | -0.83 |
| Working Capital | 9.17M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |